COMMACK, N.Y., Jan. 6 /PRNewswire/ -- In recent controlled studies conducted by Dr. Richard Bloomer, University of Memphis, scientists found that the patented ingredient in Glyc'n Go(TM), GlycoCarn(R), is the first and only proven ingredient to increase levels of nitric oxide (NO) in the body; thereby increasing blood nitrate/nitrate (NOx) in human subjects.

Nitric oxide acts as a vasodilator and enables an increase in blood flow to the skeletal muscles. This is significant to 1.) increasing oxygen and nutrient delivery for cellular energy production and 2.) removing metabolic wastes such as lactic acid and carbon dioxide. The resulting affect of an NO increase is improved performance and recovery.

Glyc'n Go(TM) is formulated in the USA by LIFEXPAND(TM). The sports supplement assists in shuttling fatty acids into the cell's mitochondria, enhancing ATP energy production. In addition to the NO and energy benefits; Glyc'n Go(TM) provides antioxidant functions by diminishing the potentially harmful effects of free radicals and aiding in the reduction of muscle tissue damage due to lactic acid build up.

Glyc'n Go(TM) delivers more pure GlycoCarn(R) per serving than any other GPLC tablet or capsule on the market today. Glyc'n Go(TM) is the only chewable form of GlycoCarn(R) and has been proven to dissolve 26% faster than tablets, enabling the product to enter the blood stream and take effect with maximum efficiency.

Glyc'n Go(TM) addresses the needs of many athletes, from strength and power, to endurance and speed. The multitude of benefits offer a number of uses to the active human body.

Glyc'n Go(TM) is manufactured in the USA by LIFEXPAND(TM), Inc. As a service and commitment to the athletic community, LIFEXPAND(TM) rigorously tests it products, including Glyc'n Go(TM), under strict protocols. Glyc'n Go(TM) is certified banned-substance free by Informed-Choice(TM) and HFL, the world's largest sports regulatory and research lab.

Glyc'n Go(TM) is available from leading supplement retailers in 60 count and 16-count individual serving packets. For more detailed information visit www.glycngo.com or call toll free 1-877-GLYCNGO.

(Date:12/9/2016)... 2016 Research and Markets has announced ... report to their offering. ... The report forecasts the global optical transceiver market to ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...

(Date:12/9/2016)... Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged ... rare diseases, today announced that senior management will participate in a ... at the InterContinental Barclay Hotel in New York City ... About aTyr Pharma ... aTyr Pharma is engaged in the discovery ...

(Date:12/9/2016)... 2016 Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...

(Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...

(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...

(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...